Clinical Trial Update: A Study to Assess How Well and Safely Elafibranor Works in Adult Participants With Primary Sclerosing Cholangitis [Phase 3]

View source ↗

Summary

Ipsen is conducting a Phase 3 clinical trial to evaluate the efficacy and safety of elafibranor in adults with primary sclerosing cholangitis; the study is curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sclerosing Cholangitis

Drugs mentioned

• Elafibranor

Snippet

Sponsor: Ipsen | Conditions: Primary Sclerosing Cholangitis | Phase 3 | Status: NOT_YET_RECRUITING